BioNexus Gene Lab Corp. Customer Advances, Current
BioNexus Gene Lab Corp. (BGLC) had Customer Advances, Current of $8.35 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › ASU 2014-09 Transition
us-gaap:CustomerAdvancesCurrent · last filed 2026-08-14
- 2026-06-30: Customer Advances, Current $8.35K.
- 2026-03-31: Customer Advances, Current $8.42K.
- 2025-12-31: Customer Advances, Current $8.38K.
- 2025-09-30: Customer Advances, Current $11.26K.
| Period end | Customer Advances, Current |
|---|---|
| 2026-06-30 | $8.35K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $8.42K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $8.38K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $11.26K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $11.35K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $21.96K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $95.88K 10-K · filed 2026-04-14 |
| 2024-09-30 | $22.83K 10-Q · filed 2024-11-15 |
| 2024-06-30 | $5.94K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $0.00 10-K · filed 2025-04-15 |
| 2023-09-30 | $8.22K 10-Q/A · filed 2024-03-26 |
| 2023-06-30 | $7.09K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $15.32K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $23.12K 10-K · filed 2024-04-16 |
| 2022-09-30 | $8.50K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $107.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $30.31K 10-K · filed 2023-03-31 |
| 2020-12-31 | $0.00 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |